Literature DB >> 10902969

Red blood cells attenuate sinusoidal endothelial cell injury by scavenging xanthine oxidase-dependent hydrogen peroxide in hyperoxic perfused rat liver.

S Motoyama1, S Saito, H Inaba, M Kitamura, Y Minamiya, H Suzuki, R Saito, S Kamata, H Nakae, J Ogawa.   

Abstract

AIMS/
BACKGROUND: Rat liver perfused with an oxygenated buffered solution alone results in degenerative changes even when the perfusion flow is accelerated to give a sufficient oxygen supply. On the other hand, perfusion media supplemented with red blood cells (RBCs) preserve the viability of the liver. The present study was conducted to clarify how RBCs protect the isolated perfused liver.
METHODS: The liver was perfused with and without RBCs in a perfusate equilibrated with supra-physiological oxygen tension at regulated inflow pressures, and controlled hepatic oxygen consumption. We examined alanine aminotransferase and purine nucleoside phosphorylase activity in the perfusate as specific markers of liver cells injury. Hydrogen peroxide (H2O2) production and morphological changes were determined using cerium electron microscopy. Apoptosis was detected by measuring CPP 32 protease activity and using TdT-mediated dUTP-digoxigenin nick end-labeling.
RESULTS: When the liver was perfused with RBC-free buffer, H2O2 production and consequent injury progressing to apoptosis were initiated in the sinusoidal endothelial cells (SECs). After SECs were injured, H2O2 appeared in the hepatocytes. H2O2 production and associated degenerative changes were attenuated both morphologically and enzymatically by the addition of RBCs, a specific xanthine oxidase (XOD) inhibitor and the H2O2 radical scavenger, catalase.
CONCLUSIONS: In the liver perfused with RBC-free buffer, H2O2 production and consequent injury were initiated in SECs. RBCs attenuate liver injury by scavenging XOD-dependent H2O2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10902969     DOI: 10.1034/j.1600-0676.2000.020003200.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  4 in total

1.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 2.  Treatment of Pancreatic Cancer with Pharmacological Ascorbate.

Authors:  John A Cieslak; Joseph J Cullen
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

3.  Effect of oxygen concentration on viability and metabolism in a fluidized-bed bioartificial liver using ³¹P and ¹³C NMR spectroscopy.

Authors:  Rex E Jeffries; Michael P Gamcsik; Kayvan R Keshari; Peter Pediaditakis; Andrey P Tikunov; Gregory B Young; Haakil Lee; Paul B Watkins; Jeffrey M Macdonald
Journal:  Tissue Eng Part C Methods       Date:  2012-09-28       Impact factor: 3.056

4.  Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress.

Authors:  Christoph Klingelhoeffer; Ulrike Kämmerer; Monika Koospal; Bettina Mühling; Manuela Schneider; Michaela Kapp; Alexander Kübler; Christoph-Thomas Germer; Christoph Otto
Journal:  BMC Complement Altern Med       Date:  2012-05-02       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.